Critics say having founder Nancy Brinker step down as CEO of Susan G. Komen for the Cure may not be enough to restore faith in the breast cancer charity, which has struggled to regain its footing since its controversial and short-lived attempt in January to cut funding to Planned Parenthood.
In a shake-up of the organization’s top management, Brinker says she will give up her role as CEO but take a new job as chairwoman of the executive committee. The departure of Komen President Liz Thompson, and two board members, Brenda Lauderback and Linda Law, also were announced Wednesday.
Longtime supporters had complained that Komen was politicizing cancer screenings, which Planned Parenthood provides, along with other services. Many called for Brinker, who founded the charity in honor of her sister, who died from breast cancer at age 36, to step down.